Dahlman Rose Reiterates a 'Buy' on Molycorp (MCP); Near-Term Results Don't Tell the Whole Story

Dahlman Rose reiterates a 'Buy' on Molycorp (NYSE: MCP), PT $125.

Dahlman analyst says, "We are adjusting our full-year 2011 and 2012 EPS estimates to $1.35 and $6.00 from $2.00 and $6.20, respectively, in order to incorporate management's most recent guidance. We are also initiating a 2Q11 EPS estimate of $0.35. Our thesis remains the same. We believe Molycorp is ideally positioned in the space, and as Phoenix rises in 2012, MCP will have tremendous earnings power."

For more ratings news on Molycorp click here and for the rating history of Molycorp click here.

Shares of Molycorp closed at $66.47 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Diana Shipping withdraws bid to acquire Genco Shipping
• Cisco rating cut at HSBC as analyst sees a lack of catalysts